The Catalyst Team
Management
- Patrick J. McEnany – Co-Founder, Chairman, President and Chief Executive Officer
- Charles W. Gorodetzky, MD, PhD – Chief Medical Officer
- Alicia Grande, CPA, CMA – Vice President, Chief Financial Officer and Treasurer
- Steven R. Miller, PhD – Chief Operating Officer and Chief Scientific Officer
- Richard P. Rieger – Vice President, Commercial Operations
- M. Douglas Winship – Vice President of Regulatory Operations
Board of Directors
- Patrick J. McEnany – Co-Founder, Chairman, President and Chief Executive Officer
- Philip H. Coelho
- Hubert E. Huckel, MD – Co-Founder
- Charles B. O'Keeffe
- David S. Tierney, MD
- Milton J. Wallace
Scientific Advisory Board
Scientific Pioneers
Drs. Stephen L. Dewey and Jonathan Brodie pioneered work on vigabatrin (CPP-109) as a treatment for addiction to cocaine and amphetamines. Their work has implications for addictions more generally, including to such substances as prescription pain medications, heroin, and nicotine.
photo courtesy Brookhaven National Laboratory